Literature DB >> 24515475

Reformatting of scFv antibodies into the scFv-Fc format and their downstream purification.

Emil Bujak1, Mattia Matasci, Dario Neri, Sarah Wulhfard.   

Abstract

The scFv-Fc format allows for rapid characterization of candidate scFvs isolated from phage display libraries before conversion into a full-length IgG. This format offers several advantages over the phage display-derived scFv, including bivalent binding, longer half-life, and Fc-mediated effector functions. Here, a detailed method is presented, which describes the cloning, expression, and purification of an scFv-Fc fragment, starting from scFv fragments obtained from a phage display library. This method facilitates the rapid screening of candidate antibodies, prior to a more time-consuming conversion into a full IgG format. Alternatively, the scFv-Fc format may be used in the clinic for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515475     DOI: 10.1007/978-1-62703-992-5_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice.

Authors:  Yuanyuan Kuang; Veronica Zorzi; Damiano Buratto; Gaia Ziraldo; Flavia Mazzarda; Chiara Peres; Chiara Nardin; Anna Maria Salvatore; Francesco Chiani; Ferdinando Scavizzi; Marcello Raspa; Min Qiang; Youjun Chu; Xiaojie Shi; Yu Li; Lili Liu; Yaru Shi; Francesco Zonta; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  EBioMedicine       Date:  2020-06-15       Impact factor: 8.143

2.  Immunity against cancer cells may promote their proliferation and metastasis.

Authors:  Chih-Wei Lin; Jia Xie; Ding Zhang; Kyung Ho Han; Geramie Grande; Nicholas C Wu; Zhuo Yang; Kyungmoo Yea; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 3.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

4.  High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Larizbeth A Romero; Takamitsu Hattori; Mohamed A E Ali; Gayatri Ketavarapu; Akiko Koide; Christopher Y Park; Shohei Koide
Journal:  J Mol Biol       Date:  2021-12-24       Impact factor: 5.469

Review 5.  Strategies and Tactics for the Development of Selective Glycan-Binding Proteins.

Authors:  Elizabeth M Ward; Megan E Kizer; Barbara Imperiali
Journal:  ACS Chem Biol       Date:  2021-01-26       Impact factor: 4.634

6.  Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin Intoxication.

Authors:  Adva Mechaly; Ron Alcalay; Tal Noy-Porat; Eyal Epstein; Yoav Gal; Ohad Mazor
Journal:  Toxins (Basel)       Date:  2018-02-13       Impact factor: 4.546

7.  Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity.

Authors:  Julia Chudzian; Anna Szlachcic; Malgorzata Zakrzewska; Miroslawa Czub; Marcin Pustula; Tad A Holak; Jacek Otlewski
Journal:  Int J Mol Sci       Date:  2018-08-21       Impact factor: 5.923

Review 8.  High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Authors:  Nicola Zambrano; Guendalina Froechlich; Dejan Lazarevic; Margherita Passariello; Alfredo Nicosia; Claudia De Lorenzo; Marco J Morelli; Emanuele Sasso
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

9.  Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders.

Authors:  Liang Xu; Andrea Carrer; Francesco Zonta; Zhihu Qu; Peixiang Ma; Sheng Li; Federico Ceriani; Damiano Buratto; Giulia Crispino; Veronica Zorzi; Gaia Ziraldo; Francesca Bruno; Chiara Nardin; Chiara Peres; Flavia Mazzarda; Anna M Salvatore; Marcello Raspa; Ferdinando Scavizzi; Youjun Chu; Sichun Xie; Xuemei Yang; Jun Liao; Xiao Liu; Wei Wang; Shanshan Wang; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  Front Mol Neurosci       Date:  2017-09-22       Impact factor: 5.639

10.  Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope.

Authors:  Adva Mechaly; Eran Diamant; Ron Alcalay; Alon Ben David; Eyal Dor; Amram Torgeman; Ada Barnea; Meni Girshengorn; Lilach Levin; Eyal Epstein; Ariel Tennenhouse; Sarel J Fleishman; Ran Zichel; Ohad Mazor
Journal:  Antibodies (Basel)       Date:  2022-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.